XTRA:FREHealthcare
Fresenius 5008X Rollout Tests Profit Ambitions And Valuation Gap
Fresenius Medical Care has launched its largest ever US product rollout with the 5008X hemodiafiltration machine.
The company is planning a broad transition of US patients to the new system, alongside a sharp improvement in profitability.
Management is framing 2026 as a transition year, with ongoing investments and adjustments to industry changes.
For investors following Fresenius SE KGaA (XTRA:FRE), the 5008X launch comes at a time when the stock trades around €51.1 and has delivered a...